PLATINUM INVESTMENT MANAGEMENT LTD - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$8,673,798
+39.0%
225,939
-31.3%
0.34%
+56.5%
Q2 2023$6,238,133
+15.9%
328,842
-5.2%
0.22%
+15.5%
Q1 2023$5,381,505
-26.3%
346,970
-15.6%
0.19%
-32.7%
Q4 2022$7,300,522
+98.5%
411,297
-37.6%
0.28%
+80.5%
Q3 2022$3,678,000
+21.3%
659,075
-15.2%
0.15%
+33.9%
Q2 2022$3,033,000
-19.8%
777,590
+13.2%
0.12%
-0.9%
Q1 2022$3,783,000
-27.9%
686,660
+11.5%
0.12%
-20.5%
Q4 2021$5,247,000
+8.8%
615,900
+11.0%
0.15%
+7.4%
Q3 2021$4,824,000555,0650.14%
Other shareholders
IMMUNOVANT INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders